Next Article in Journal
Association of Marijuana Use and Cyclic Vomiting Syndrome
Next Article in Special Issue
The Chemical Components of Sesbania grandiflora Root and Their Antituberculosis Activity
Previous Article in Journal
Pertuzumab Increases 17-AAG-Induced Degradation of ErbB2, and This Effect Is Further Increased by Combining Pertuzumab with Trastuzumab
Pharmaceuticals 2012, 5(7), 690-718; doi:10.3390/ph5070690
Review

Chemotherapeutic Interventions Against Tuberculosis

1, 2, 3 and 1,*
Received: 15 May 2012; in revised form: 12 June 2012 / Accepted: 21 June 2012 / Published: 28 June 2012
(This article belongs to the Special Issue Antituberculosis Drugs)
Abstract: Tuberculosis is the second leading cause of infectious deaths globally. Many effective conventional antimycobacterial drugs have been available, however, emergence of multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) has overshadowed the effectiveness of the current first and second line drugs. Further, currently available agents are complicated by serious side effects, drug interactions and long-term administration. This has prompted urgent research efforts in the discovery and development of new anti-tuberculosis agent(s). Several families of compounds are currently being explored for the treatment of tuberculosis. This review article presents an account of the existing chemotherapeutics and highlights the therapeutic potential of emerging molecules that are at different stages of development for the management of tuberculosis disease.
Keywords: tuberculosis chemotherapy; mycobacterium; drug-resistant tuberculosis; emerging TB drugs tuberculosis chemotherapy; mycobacterium; drug-resistant tuberculosis; emerging TB drugs
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Shakya, N.; Garg, G.; Agrawal, B.; Kumar, R. Chemotherapeutic Interventions Against Tuberculosis. Pharmaceuticals 2012, 5, 690-718.

AMA Style

Shakya N, Garg G, Agrawal B, Kumar R. Chemotherapeutic Interventions Against Tuberculosis. Pharmaceuticals. 2012; 5(7):690-718.

Chicago/Turabian Style

Shakya, Neeraj; Garg, Gaurav; Agrawal, Babita; Kumar, Rakesh. 2012. "Chemotherapeutic Interventions Against Tuberculosis." Pharmaceuticals 5, no. 7: 690-718.


Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert